{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T04:23:38Z","timestamp":1648700618750},"reference-count":40,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Pharmacologica Japonica","Folia Pharmacol. Jpn."],"published-print":{"date-parts":[[2002]]},"DOI":"10.1254\/fpj.119.29","type":"journal-article","created":{"date-parts":[[2004,4,13]],"date-time":"2004-04-13T06:04:58Z","timestamp":1081836298000},"page":"29-35","source":"Crossref","is-referenced-by-count":3,"title":["Biological and pathophysiological roles of endogenous methylarginines as inhibitors of nitric oxide synthase"],"prefix":"10.1254","volume":"119","author":[{"given":"Hitoshi","family":"MASUDA","sequence":"first","affiliation":[{"name":"Department of Urology & Reproductive Medicine, Tokyo Medical & Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"AZUMA","sequence":"additional","affiliation":[{"name":"Department of Molecular Design, Institute of Biomaterials & Bioengineering, Graduate School, Tokyo Medical & Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kakimoto Y and Akazawa S: Isolation and identification of <i>N<\/i><sup>G<\/sup>,<i>N<\/i><sup>G<\/sup>- and <i>N<\/i><sup>G<\/sup>,<i>N<\/i>'<sup>G<\/sup>-dimethylarginine, <i>N<\/i><sup>G<\/sup>-mono, di, trimethyllysine and glucosyl, galactosyl and galactosyl-&delta;-hydroxylysine from human urine. J Biol Chem 245, 5751-5758 (1970)","DOI":"10.1016\/S0021-9258(18)62716-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Nakajima T, Matsuoka Y and Kakimoto Y: Isolation and identification of <i>N<\/i><sup>G<\/sup>-monomethyl-, <i>N<\/i><sup>G<\/sup>,<i>N<\/i><sup>G<\/sup>-dimethyl- and <i>N<\/i><sup>G<\/sup>,<i>N<\/i>'<sup>G<\/sup>-dimethylarginine from the hydrolysates of bovine brain. Biochim Biophys Acta 230, 212-222 (1970)","DOI":"10.1016\/0304-4165(71)90206-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Drapier JC and Hibbs JB: Murine cytotoxic activated macrophages inhibit aconitase in tumor cells-inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest 78, 790-797 (1986)","DOI":"10.1172\/JCI112642"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) Vallance P, Leone P, Calver A, Collier J and Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339, 572-575 (1992)","DOI":"10.1016\/0140-6736(92)90865-Z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Shubert B, Tsikas D and Bode-Boger SM: LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells. Involvement of <i>S<\/i>-adenosylmethionine-dependent methyltransferases. Circ Res 87, 99-105 (2000)","DOI":"10.1161\/01.RES.87.2.99"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ogawa T, Kimoto M and Sasaoka K: Purification and properties of a new enzyme. <i>N<\/i><sup>G<\/sup>,<i>N<\/i><sup>G<\/sup>-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 264, 10205-10209 (1989)","DOI":"10.1016\/S0021-9258(18)81786-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tojo A, Welch WJ, Bremer V, Kimoto M, Kimura K, Omata M, Ogawa T, Vallance P and Wilcox CS: Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int 52, 1593-1601 (1997)","DOI":"10.1038\/ki.1997.490"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kimoto M, Whitley GStJ, Tsuji H and Ogawa T: Detection of <i>N<\/i><sup>G<\/sup>, <i>N<\/i><sup>G<\/sup>-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem (Tokyo) 117, 237-238 (1995)","DOI":"10.1093\/jb\/117.2.237"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russel RJ, Hodson H, Whitley GStJ and Vallance P: Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 119, 1533-1540 (1996)","DOI":"10.1111\/j.1476-5381.1996.tb16069.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Bogle RG, MacAllister RJ, Whitley GStJ and Vallance P: Induction of <i>N<\/i><sup>G<\/sup>-monomethyl-L-arginine uptake: a mechanism for differential inhibition of synthase? Am J Physiol 269, C750-756 (1995)","DOI":"10.1152\/ajpcell.1995.269.3.C750"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) McDonald KK, Zharikov S, Block ER and Kilberg MS: A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the&ldquo;arginine paradox&rdquo;. J Biol Chem 272, 31213-31216 (1997)","DOI":"10.1074\/jbc.272.50.31213"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) MacAllister RJ and Vallance P: Nitric oxide in essential and renal hypertension. J Am Soc Nephrol 5, 1057-1065 (1994)","DOI":"10.1681\/ASN.V541057"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Xia Y, Dawson VL, Dawson TM, Snyder SH and Zweier JL: Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93, 6770-6774 (1996)","DOI":"10.1073\/pnas.93.13.6770"},{"key":"14","first-page":"667","volume":"96","year":"1992","unstructured":"14) Huk I, Nanobashvili J, Neumayer C, Punz A, Mueller M, Afkhampour K, Mittlboeck M, Losert U, Polterauer P, Roth E, et al: L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia\/reperfusion injury in skeletal muscle. Circulation 96, 667-675 (1992)","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15) Olken NM and Marletta MA: <i>N<\/i><sup>G<\/sup>-Methyl-L-arginine functions as an alternative substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry 32, 9677-9685 (1993)","DOI":"10.1021\/bi00088a020"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Boger RH, Bode-Boger SM, Tsao PS, Lin PS, Chan JR and Cooke JP: An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol 36, 2287-2295 (2000)","DOI":"10.1016\/S0735-1097(00)01013-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Grisham MB, Granger DN and Lefer DJ: Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitric oxide: relevance to ischemic heart disease. Free Radic Biol Med 25, 404-433 (1998)","DOI":"10.1016\/S0891-5849(98)00094-X"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Azuma H, Ishikawa M and Sekizaki S: Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 88, 411-415 (1986)","DOI":"10.1111\/j.1476-5381.1986.tb10218.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Garg UC and Hassid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83, 1774-1777 (1989)","DOI":"10.1172\/JCI114081"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Niimi Y, Azuma H and Hirakawa K: Repeated endothelial removal augments intimal thickening and attenuates EDRF release. Am J Physiol 266, H1348-H1356 (1994)","DOI":"10.1152\/ajpheart.1994.266.4.H1348"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Azuma H, Obayashi S, Hamasaki H, Koyama T and Aso T: Role of endothelium in the human uterine arteries during normal menstrual cycle. Br J Pharmacol 114, 902-908 (1995)","DOI":"10.1111\/j.1476-5381.1995.tb13289.x"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22) Boger RH, Bode-Beger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF and Cook JP: Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: Its role in hypercholesterolemia. Circulation 98, 1842-1847 (1998)","DOI":"10.1161\/01.CIR.98.18.1842"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S and Imaizumi T: Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 62, 2425-2430 (1998)","DOI":"10.1016\/S0024-3205(98)00225-2"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24) Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S and Imaizumi T: Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis. Circulation 99, 1141-1146 (1999)","DOI":"10.1161\/01.CIR.99.9.1141"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kielstein JT, Boger RH, Bode-Boger SM, Schaffer J, Barbey M, Koch KM and Frolich JC: Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10, 594-600 (1999)","DOI":"10.1681\/ASN.V103594"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) MacAllister RJ and Vallance P: Nitric oxide in essential and renal hypertension. J Am Soc Nephrol 5, 1057-1065 (1994)","DOI":"10.1681\/ASN.V541057"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Boger RH, Bode-Boger SM, Thiele W, Creutzig A, Alexander K and Frolich JC: Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol 32, 1336-1344 (1998)","DOI":"10.1016\/S0735-1097(98)00375-1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Herlitz H, Petersson A, Sigstrom L, Wennmalm A and Westberg G: The arginine-nitric oxide pathway in thrombotic microangiopathy. Scand J Urol Nephrol 31, 477-479 (1997)","DOI":"10.3109\/00365599709030646"},{"key":"29","first-page":"242","volume":"342","year":"1993","unstructured":"29) Fickling SA, Williams D, Vallance P, Nussey SS and Whitley GStJ: Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 342, 242-243 (1993)","journal-title":"The Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Chan JR, Boger RH, Bode-Boger SM, Tangphao O, Tsao PS, Blaschke TF and Cooke JP: Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol 20, 1040-1046 (2000)","DOI":"10.1161\/01.ATV.20.4.1040"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Azuma H, Sato J, Hamasaki H, Sugimoto A, Isotani E and Obayashi S: Accumulation of endogenous inhibitor for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells. Br J Pharmacol 115, 1001-1004 (1995)","DOI":"10.1111\/j.1476-5381.1995.tb15910.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Masuda H, Goto M, Tamaoki S and Azuma H: Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. Br J Pharmacol 126, 211-218 (1999)","DOI":"10.1038\/sj.bjp.0702298"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Sato J, Masuda H, Tamaoki S, Hamasaki H, Ishizaka K, Matsubara O and Azuma H: Endogenous asymmetrical dimethylarginine and hypertension associated with puromycin nephrosis in the rat. Br J Pharmacol 125, 469-476 (1998)","DOI":"10.1038\/sj.bjp.0702101"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34) Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T and Cooke JP: Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimetylaminohydrolase. Circulation 99, 3092-3095 (1999)","DOI":"10.1161\/01.CIR.99.24.3092"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D and Bode-Beger SM: LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: Involvement of <i>S<\/i>-adenosylmethionine-dependent methyltransferases. Circ Res 87, 99-105 (2000)","DOI":"10.1161\/01.RES.87.2.99"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Masuda H, Tsujii T, Okuno T, Kihara K, Goto M and Azuma H: Involvement of accumulated endogenous NOS inhibitors and decreased NOS activity in the impaired neurogenic relaxation of the rabbit proximal urethra with ischemia. Br J Pharmacol 133, 97-106 (2001)","DOI":"10.1038\/sj.bjp.0704050"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Charles IG, Whitley GStJ and Vallance P: Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deminases. Biochem J 343, 209-214 (1999)","DOI":"10.1042\/bj3430209"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Das I, Khan NS, Puri BK and Hirsch SR: Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neurosci Lett 215, 209-211 (1996)","DOI":"10.1016\/0304-3940(96)12972-4"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Rawal N, Lee Y-L, Whitaker JN, Park JO, Paik WK and Kim S: Urinary excretion of <i>N<\/i><sup>G<\/sup>-dimethylarginines in multiple sclerosis patients: preliminary observations. J Neurol Sci 129, 186-191 (1995)","DOI":"10.1016\/0022-510X(94)00277-U"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Faraci FM, Brian JE and Hcistad DD: Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol 269, H1522-H1527 (1995)","DOI":"10.1152\/ajpheart.1995.269.5.H1522"}],"container-title":["Folia Pharmacologica Japonica"],"original-title":["\u5185\u56e0\u6027NOS\u963b\u5bb3\u7269\u8cea\u3068\u75be\u75c5"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/119\/1\/119_1_29\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T14:51:46Z","timestamp":1623768706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/119\/1\/119_1_29\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002]]}},"URL":"https:\/\/doi.org\/10.1254\/fpj.119.29","relation":{},"ISSN":["0015-5691","1347-8397"],"issn-type":[{"value":"0015-5691","type":"print"},{"value":"1347-8397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002]]}}}